B&D White Capital Company LLC Acquires Shares of 9,300 CVS Health Co. (NYSE:CVS)

B&D White Capital Company LLC bought a new position in CVS Health Co. (NYSE:CVS) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 9,300 shares of the pharmacy operator’s stock, valued at approximately $417,000.

Other large investors have also recently modified their holdings of the company. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the 3rd quarter valued at approximately $25,000. Ridgewood Investments LLC lifted its stake in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $28,000. Legacy Investment Solutions LLC bought a new position in CVS Health in the third quarter worth $31,000. Finally, Reston Wealth Management LLC purchased a new position in CVS Health during the third quarter valued at $32,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday, February 12th. Piper Sandler lowered their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. StockNews.com raised CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday, February 13th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Finally, Barclays raised their price target on CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $70.00.

Insider Transactions at CVS Health

In related news, Director Michael F. Mahoney purchased 30,000 shares of CVS Health stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.24% of the stock is currently owned by company insiders.

CVS Health Price Performance

NYSE CVS opened at $63.42 on Monday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The stock has a market capitalization of $79.95 billion, a price-to-earnings ratio of 17.33, a PEG ratio of 0.98 and a beta of 0.61. The business’s fifty day moving average price is $52.39 and its 200-day moving average price is $56.20.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, equities analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.19%. The ex-dividend date was Thursday, January 23rd. CVS Health’s payout ratio is 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.